U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985537) titled 'Steroid Injection in Idiopathic Granulomatous Mastitis' on Dec. 11, 2024.
Brief Summary: Granulomatous mastitis (GM) is a non-infectious inflammatory breast condition typically affecting young women, often following breastfeeding. Management of GM often begins with anti-inflammatory medications and antibiotics. Steroids, particularly intralesional corticosteroids, are considered the first-line treatment for GM due to their rapid anti-inflammatory and immunosuppressive effects. Steroids help control symptoms such as painful lumps, swelling, and redness. Steroids' effectiveness in providing symptom relief minimizes the need for more in...